Back to List
Medicare's New ACCESS Program Shifts to Outcome-Based Payments to Foster AI Innovation in Healthcare Delivery
Industry NewsMedicareArtificial IntelligenceHealthcare Tech

Medicare's New ACCESS Program Shifts to Outcome-Based Payments to Foster AI Innovation in Healthcare Delivery

The Centers for Medicare & Medicaid Services (CMS) has introduced the ACCESS program, a transformative 10-year initiative designed to test AI-driven medical care at a federal scale. By selecting 150 participants, including the healthcare startup Pair Team, the program aims to move away from traditional fee-for-service models that reimburse based on clinician time. Instead, the ACCESS model rewards measurable health outcomes for chronic conditions such as diabetes, hypertension, and depression. This shift creates a critical financial pathway for AI agents and automated monitoring systems that were previously excluded from federal reimbursement structures. Industry experts suggest this marks a significant move toward creating 'swim lanes' for AI innovation within highly regulated sectors, allowing the most effective technological solutions to succeed based on patient results rather than administrative activity.

Hacker News

Key Takeaways

  • Shift to Outcome-Based Payments: Medicare is moving from reimbursing clinician time to rewarding measurable health outcomes, such as lower blood pressure or reduced pain.
  • The ACCESS Program: A 10-year CMS initiative involving 150 participants designed to test scalable, AI-driven solutions for chronic care management.
  • Financial Pathway for AI: The new model provides a mechanism to pay for AI-driven activities like patient monitoring and care coordination that traditional Medicare does not cover.
  • Focus on Chronic Conditions: The program specifically targets high-impact areas including diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety.
  • Regulatory Innovation: The initiative creates dedicated 'swim lanes' for AI, allowing the best technological solutions to compete in traditionally rigid healthcare environments.

In-Depth Analysis

Breaking the Time-Based Reimbursement Barrier

For decades, the traditional Medicare reimbursement structure has been a significant hurdle for the integration of artificial intelligence in clinical settings. Under the standard model, payments are primarily tied to the time a clinician spends with a patient. This legacy system lacks a formal mechanism to compensate for the value provided by AI agents that operate between visits. These digital tools—which can monitor patient vitals, conduct automated check-ins, coordinate housing referrals, or ensure medication adherence—do not fit into the 'minutes-per-visit' calculation.

The ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) program addresses this fundamental misalignment. By providing predictable payments for managing qualifying conditions and only awarding the full amount when specific health goals are met, CMS is effectively decoupling healthcare revenue from human labor hours. This transition is essential for AI adoption, as it allows healthcare providers to utilize automated systems to achieve the required health outcomes without losing the financial support that traditionally required a physical or synchronous human presence.

Creating 'Swim Lanes' for AI Innovation

According to Neil Batlivala, CEO of Pair Team—one of the 150 organizations selected for the program—the government is intentionally creating 'swim lanes' for AI innovation. In many regulated industries, the most effective solution does not always win due to bureaucratic hurdles and rigid payment structures. The healthcare sector, in particular, has been slow to adopt cutting-edge technology because the financial incentives were not aligned with technological efficiency.

With the launch of ACCESS on July 5, the federal government is signaling a shift toward a 'best solution wins' philosophy. By focusing on outcomes for chronic diseases like chronic kidney disease and anxiety, the program allows tech-driven companies to prove that AI can manage patient populations more effectively than traditional methods alone. This creates a competitive environment where the efficacy of an AI agent's monitoring or coordination is directly tied to the financial success of the participating healthcare organization.

Industry Impact

The implications of the ACCESS program extend far beyond the 150 initial participants. By establishing a federal-scale testing ground for AI-driven care, CMS is providing a blueprint for how regulated industries can integrate emerging technologies. For the AI industry, this represents the opening of a massive, previously inaccessible market: federal healthcare spending.

If the 10-year program successfully demonstrates that AI-driven care leads to better health outcomes at a lower or more predictable cost, it could lead to a permanent overhaul of how Medicare—and subsequently private insurers—reimburses for medical services. This would likely trigger a surge in investment toward AI healthcare startups that focus on chronic disease management and automated patient navigation, as the 'regulatory moat' that once protected traditional practices begins to transform into a gateway for technological innovation.

Frequently Asked Questions

Question: What is the Medicare ACCESS program?

ACCESS stands for Advancing Chronic Care with Effective, Scalable Solutions. It is a 10-year program launched by the Centers for Medicare & Medicaid Services (CMS) to test a new payment model that rewards health outcomes rather than the volume of clinician activities. It involves 150 participating organizations and is scheduled to go live on July 5.

Question: Why is this payment model better for AI than traditional Medicare?

Traditional Medicare pays based on the time a clinician spends with a patient, which offers no way to pay for AI tools that monitor patients or coordinate care automatically. The ACCESS model pays for results (like lower blood pressure), allowing providers to use AI agents to achieve those results and still receive payment, even if a human clinician isn't involved in every step.

Question: Which medical conditions are covered under the ACCESS program?

The program focuses on managing several chronic conditions, specifically diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety.

Related News

Meituan Technical Team Showcases 32 Top-Tier AI Conference Papers Including ACL 2026 Outstanding Award
Industry News

Meituan Technical Team Showcases 32 Top-Tier AI Conference Papers Including ACL 2026 Outstanding Award

Meituan's technical team has announced a major academic milestone for 2026, with dozens of research papers accepted by world-renowned AI conferences including ACL, SIGIR, ICML, and KDD. To share these findings, the team curated 32 standout papers and conducted five specialized live broadcast sessions. A primary highlight of this year's achievement is the inclusion of an Outstanding Paper award from ACL 2026, underscoring the high quality of Meituan's contributions to Natural Language Processing. The company has now made the playback of these sessions available, providing the global technical community with in-depth analysis and insights into their latest advancements in machine learning, information retrieval, and data mining.

Meituan Technical Team Showcases Cutting-Edge Machine Learning Research at ICML 2026 International Conference
Industry News

Meituan Technical Team Showcases Cutting-Edge Machine Learning Research at ICML 2026 International Conference

The Meituan Technical Team has officially announced the selection of its academic research papers for ICML 2026, one of the most influential international conferences in the machine learning field. ICML serves as a premier global platform for addressing the critical challenges and core issues that define the future of artificial intelligence. By evaluating and promoting research that offers significant theoretical value and practical impact, the conference aims to drive industry-wide progress and establish future research trajectories. Meituan's participation in this prestigious event underscores its commitment to advancing the frontiers of machine learning through rigorous academic contributions. The selection highlights the team's focus on bridging the gap between complex theoretical frameworks and real-world industrial applications, ensuring that their research leads the way in shaping the next generation of machine learning technologies.

Meituan Fulfillment AI Team Unveils Advanced Agent Technology and ACL 2026 Research for Self-Evolving Systems
Industry News

Meituan Fulfillment AI Team Unveils Advanced Agent Technology and ACL 2026 Research for Self-Evolving Systems

The Meituan Fulfillment AI Algorithm team has announced a specialized session focusing on their contributions to ACL 2026 and their ongoing research into Large Language Model (LLM) based Agent systems. The team is dedicated to building a self-evolving Agent operating system designed to enhance Meituan's fulfillment business. Key research areas include Continuous Pre-training (CPT), Post-training, Agentic Reinforcement Learning (RL), and multimodal understanding. With a history of high-quality publications in prestigious venues like ACL and EMNLP, this session highlights the practical application of frontier AI technologies in complex, real-world service environments. The initiative represents a significant step in integrating generative AI with operational logistics to create more autonomous and adaptive business systems.